# Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59)

> **NCT00591643** · PHASE1 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 93 (actual)

## Conditions studied

- Adrenal Tumors
- Adrenal Malignancies
- Abnormal Hormonal Secretions
- Electrolytes Abnormalities

## Interventions

- **PROCEDURE:** Imaging, Adrenal acans
- **RADIATION:** (NP-59)

## Key facts

- **NCT ID:** NCT00591643
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1977-07
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2015-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00591643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00591643, "Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59)". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00591643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*